RxDoctor Payments Data

Eric Wang, MD

Otolaryngology · Pittsburgh, PANPI 1073631313

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,620 of the $14,788 with a category attached, or 71.8%. Stryker accounts for 76.5% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $11,775, more than ten times the $99 reported in 2019. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,788in general payments, 2019–2025

Across 44 payments — averaging $336.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$11K
  • Medtronic$3K
  • Integra Lifesciences Corporation$239
  • Acclarent, Inc$228
  • Bausch & Lomb Americas Inc.$15
$9,243in research payments, 2019–2025

Across 2 payments — averaging $4621.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$9K

What the payments were for

  • Consulting fees$10,62072%
  • Travel & lodging$2,51517%
  • Food & beverage$1,65311%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,788 in reported general payments places this provider in the 90th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$124,290
Medicare patients
146
Services billed
560

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mometasone Furoate26$2,145
Azelastine Hcl96$2,127
Fluticasone Propionate158$1,769
Ipratropium Bromide56$1,506
Acetazolamide12$467
Mupirocin54$285
Omeprazole19$266
Doxycycline Hyclate22$146
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$144
Methylprednisolone13$52
Montelukast Sodium19$32
Prednisone17$17

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →